Notes from DrKF:
In 2018, this methylation adaptogen was shown to be beneficial as a senolytic agent in old mice and in human tissue, meaning, it made the mice immunologically younger and less inflamed. Other animal studies show fisetin to be antioxidant, anti-tumerogenic (anti-cancer), cardio- and neuro-protective and anti-inflammatory. A small study looking at inflammatory markers in colon cancer patients showed benefit at only 100 mg/day. Stay tuned for larger human studies.
Dosage: 100 mg per day.